Quest Diagnostics (DGX) PT Raised to $195 at Barclays
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $236.59 +0.93%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Barclays analyst Stephanie Davis raised the price target on Quest Diagnostics (NYSE: DGX) to $195.00 (from $190.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
